KANAPH THERAPEUTICS
Kanaph Therapeutics is a biotech with activities that range from drug discovery to early-stage clinical trials. We are dedicated to developing next-generation therapeutics for oncology and autoimmune diseases. Our oncology pipeline includes bi-specific antibodies and small molecules that have a greatly enhanced immuno-stimulatory activity in the tumor microenvironment (TME) for efficient tumor eradication. Our autoimmune disease pipeline is composed of bispecific Fc-fusions that inhibit the alternative complement pathway while inhibiting angiogenesis and downstream complement activation as well.
KANAPH THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-02-14
Address:
Yongsan, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.kanaphtx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Content Delivery Network Euro Google Maps JsDelivr AJAX Libraries API Pound Sterling
Current Employees Featured
Founder
Investors List
Time Folio Asset Management
Time Folio Asset Management investment in Series B - Kanaph Therapeutics
Green Cross
Green Cross investment in Series B - Kanaph Therapeutics
Kolon Investment
Kolon Investment investment in Series B - Kanaph Therapeutics
Time Folio Asset Management
Time Folio Asset Management investment in Series A - Kanaph Therapeutics
Meritz Securities
Meritz Securities investment in Series A - Kanaph Therapeutics
Official Site Inspections
http://www.kanaphtx.com
- Host name: 112.175.85.184
- IP address: 112.175.85.184
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Kanaph Therapeutics"
(์ฃผ)์นด๋ํํ ๋ผํจํฑ์ค
Biotech in drug discovery and development with focus on immuno-oncologySee details»
Kanaph Therapeutics - Crunchbase Company Profile & Funding
Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.See details»
Kanaph Therapeutics - LinkedIn
Kanaph Therapeutics is a drug discovery and pre-clinical stage biotech based in Korea, with a large and small molecule two-track strategy for the development of first-in-class and best-in-class ...See details»
(์ฃผ)์นด๋ํํ ๋ผํจํฑ์ค - ABOUT - ABOUT - kanaphtx.com
Kanaph Therapeutics is a biotech with activities that range from drug discovery to early stage clinical trials. We are dedicated to developing next generation therapeutics for oncology and autoimmune diseases. Our oncology pipeline โฆSee details»
Kanaph Therapeutics 2025 Company Profile: Valuation, โฆ
Information on valuation, funding, cap tables, investors, and executives for Kanaph Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Kanaph Therapeutics - VentureRadar
VentureRadar Research / Company Website Dansk Biotek DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for โฆSee details»
Kanaph Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kanaph Therapeutics Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
Kanaph - Company Profile - Tracxn
Feb 25, 2025 KANAPH Therapeutics is a developer of immunocytokine platform for T-cell based cancer treatment. The company uses the immunocytokine platform called TMEkine to activate โฆSee details»
KANAPH Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Kanaph Therapeutics operates in the biotechnology sector, with a focus on discovering drugs and conducting initial clinical trials. The company is committed to creating advanced treatments for โฆSee details»
KANAPH Therapeutics, Inc.:Company Profile & Technical Research ...
Discovery Company profile page for KANAPH Therapeutics, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Overview, News & Similar companies - ZoomInfo.com
Oct 13, 2020 View Kanaph Therapeutics (www.kanaphtx.com) location in South Korea , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Kanaph - Products, Competitors, Financials, Employees, โฆ
About Kanaph Kanaph Therapeutics Inc. is a biotech company focused on drug discovery and pre-clinical development within the fields of immuno-oncology, targeted therapy, and โฆSee details»
KANAPH Therapeutics, Inc. (KANAPH Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
ไบ่งฃKANAPH Therapeutics, Inc. (KANAPH Therapeutics, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผ็ฅ็ป็ณป็ป็พ็ ๏ผๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผๆๆฏๅนณๅฐ:ๅฐๅ โฆSee details»
(์ฃผ)์นด๋ํํ ๋ผํจํฑ์ค - SCIENCE - SCIENCE - mail.kanaphtx.com
Kanaph focuses on the research and development of innovative therapeutic molecules to provide solutions for unmet medical needs in cancer and autoimmune diseases. With both large โฆSee details»
Kanaph Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Kanaph Therapeutics Inc. | Insights
Nov 5, 2024 With the long-awaited global commercialization of lazertinib, Oscotec Inc. and its US subsidiary Genosco, the originators of the novel lung cancer drug, are poised to see a โฆSee details»
Kanaph Therapeutics Closes 21M USD Series B Funding
Oct 13, 2020 /PRNewswire/ -- Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules, recently completed...See details»
(์ฃผ)์นด๋ํํ ๋ผํจํฑ์ค - NEWS - NEWS - website.kanaphtx.com
Biotech in drug discovery and development with focus on immuno-oncologySee details»
(์ฃผ)์นด๋ํํ ๋ผํจํฑ์ค - NEWS - NEWS - website.kanaphtx.com
Biotech in drug discovery and development with focus on immuno-oncologySee details»
Governor Abbott Launches NARCAN Locator Map As Part Of "One โฆ
3 days ago March 26, 2025 | Austin, Texas | Press Release Governor Greg Abbott announced the launch of an online interactive map by the Texas Department of State Health Services โฆSee details»